Submitted by Anonymous (not verified) on 25 March 2026 - 15:41
Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Date of authorisation: 14/02/2019, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Date of authorisation: 14/02/2019, Revision: 19, Status: Authorised